Stockscreener 앱 받기
0.962
1.27%
0.0121
Standard Biotools Inc 주식(LAB)의 최신 뉴스
Downgrade Watch: Will Standard BioTools Inc stock hit new highs in YEAR2026 Fed Impact & High Return Trade Opportunity Guides - baoquankhu1.vn
Analysis Recap: Is Standard BioTools Inc impacted by rising rates2026 Sentiment & Risk Managed Investment Entry Signals - baoquankhu1.vn
Earnings Risk: Is Standard BioTools Inc impacted by rising rates2026 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Pullback Watch: Does Standard BioTools Inc have declining or rising EPSMarket Sentiment Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Whale Trades: Can Standard BioTools Inc stock double in the next yearGDP Growth & Safe Entry Momentum Tips - baoquankhu1.vn
Long Focus Capital Management LLC Acquires 1,292,804 Shares of Standard BioTools Inc. $LAB - MarketBeat
Standard BioTools Inc. $LAB Shares Purchased by Mak Capital One LLC - MarketBeat
Standard BioTools Inc. 2025 Annual Report: Market Overview, Innovation, and Regulatory Landscape in Life Sciences Tools - Minichart
Standard BioTools 2025 10-K: Revenue $85.3M, EPS $(0.20) - TradingView
Standard BioTools (NASDAQ: LAB) refocuses on core tools after SomaScan sale - Stock Titan
Standard BioTools Inc. $LAB Stake Boosted by Casdin Capital LLC - MarketBeat
Shorts Report: Can Standard BioTools Inc grow without dilution2026 Trading Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) Cut to "Sell" at Wall Street Zen - MarketBeat
Retail Trends: Will Standard BioTools Inc stock hit new highs in YEARWeekly Market Report & Fast Momentum Entry Tips - baoquankhu1.vn
Does Standard BioTools Inc have declining or rising EPSJuly 2025 Chart Watch & Fast Momentum Entry Tips - baoquankhu1.vn
Aug PostEarnings: Should I invest in Standard BioTools Inc before earningsQuarterly Trade Summary & Expert Verified Movement Alerts - baoquankhu1.vn
LAB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LAB Technical Analysis & ETF Price Forecast - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Eli Casdin boosts equity stake in STANDARD BIOTOOLS (LAB) with 52,991 RSUs - Stock Titan
STANDARD BIOTOOLS (LAB) director takes 51,282 RSUs in lieu of $60K cash - Stock Titan
Retail Trends: Is Standard BioTools Inc a strong growth stockJuly 2025 Analyst Calls & Weekly High Return Opportunities - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) Upgraded to Hold at Wall Street Zen - MarketBeat
Standard BioTools Inc. (LAB) Stock Analysis: Unveiling a 32% Upside Potential Amidst Challenging Metrics - DirectorsTalk Interviews
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED), Standard BioTools (LAB) and Addus Homecare (ADUS) - The Globe and Mail
Standard BioTools (LAB) Q4 Profit Challenges Longstanding Unprofitable Narrative - Sahm
Standard BioTools Q4 2025 Results: Profit on $23.8M RevenueNews and Statistics - IndexBox
Standard BioTools Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Standard BioTools (LAB) Reports Strong Q4 Revenue Exceeding Expe - GuruFocus
Standard BioTools Inc (NASDAQ:LAB) Surges on Strong Q4 Earnings Beat - ChartMill
STANDARD BIOTOOLS (LAB) CEO has shares withheld to cover RSU tax bill - Stock Titan
Standard BioTools (LAB) SVP disposes shares for tax withholding - Stock Titan
Tax withholding trims Standard BioTools (LAB) CFO share stake - Stock Titan
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results - Investing News Network
Standard Biotools earnings beat by $0.10, revenue topped estimates - Investing.com Canada
Standard BioTools Details SomaLogic Sale and Profitability Path - TipRanks
LAB Forecasts Revenue Between $80 Million and $85 Million for FY - GuruFocus
Standard BioTools: Q4 Earnings Snapshot - marketscreener.com
Standard BioTools (NASDAQ:LAB) Announces Earnings Results - MarketBeat
Standard BioTools Q4 Earnings Report: What Investors Need to Know - Benzinga
Preview: Standard BioTools's Earnings - Benzinga
LABSTANDARD BIOTOOLS INC Latest Stock News & Market Updates - Stock Titan
Standard BioTools Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Standard BioTools Inc. (LAB) Stock Analysis: Healthcare Innovator Shows 34.78% Potential Upside - DirectorsTalk Interviews
What hedge fund activity signals for Standard BioTools Inc. stock2025 Geopolitical Influence & Short-Term High Return Ideas - mfd.ru
MSN Money - MSN
Standard BioTools (LAB) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
How Standard BioTools Inc. stock performs during Fed tightening cyclesWeekly Trend Recap & Short-Term Trading Alerts - mfd.ru
Illumina Stock May Benefit From New Agreement to Acquire SomaLogic - MSN
Illumina completes acquisition of SomaLogic from Standard BioTools - BizWest
Standard BioTools Inc. (LAB) Stock Analysis: Unpacking a 39.64% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
LAB PE Ratio & Valuation, Is LAB Overvalued - Intellectia AI
1.53%
자본화:
|
볼륨(24시간):